Physician profile
Meagan Call
NPI 1972083822
$329.29
in general payments reported to CMS, 2019-2025
11 companies · $24.43 in 2025
The $24.43 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $148 · 2023: $18.15 · 2024: $139 · 2025: $24.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $72.38 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaqta |
| Ironshore Pharmaceuticals INC. | $48.98 | 2024 | |
| Corium, LLC | $41.83 | 2024 | Azstarys |
| Tris Pharma INC | $35.41 | 2022 | |
| Supernus Pharmaceuticals, INC. | $33.88 | 2022-2024 | Qelbree |
| Pfizer INC. | $18.15 | 2023 | |
| Acadia Pharmaceuticals INC | $17.86 | 2024 | Daybue |
| Seqirus USA INC | $16.88 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.21 | 2022 | |
| Sobi, INC | $15.99 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.